BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 16860764)

  • 41. Mini-review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming?
    Melief CJ
    Eur J Immunol; 2003 Oct; 33(10):2645-54. PubMed ID: 14515248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation.
    Chhabra A; Mehrotra S; Chakraborty NG; Mukherji B; Dorsky DI
    Eur J Immunol; 2004 Oct; 34(10):2824-33. PubMed ID: 15368298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.
    Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptor 3 promotes cross-priming to virus-infected cells.
    Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Reis e Sousa C
    Nature; 2005 Feb; 433(7028):887-92. PubMed ID: 15711573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
    Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
    J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity.
    Hugues S; Fetler L; Bonifaz L; Helft J; Amblard F; Amigorena S
    Nat Immunol; 2004 Dec; 5(12):1235-42. PubMed ID: 15516925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.
    Yoneyama H; Matsuno K; Toda E; Nishiwaki T; Matsuo N; Nakano A; Narumi S; Lu B; Gerard C; Ishikawa S; Matsushima K
    J Exp Med; 2005 Aug; 202(3):425-35. PubMed ID: 16061729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stress presents a problem for dendritic cells: corticosterone and the fate of MHC class I antigen processing and presentation.
    Truckenmiller ME; Bonneau RH; Norbury CC
    Brain Behav Immun; 2006 May; 20(3):210-8. PubMed ID: 16504465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].
    Tan XH; Liu C; Wan YH
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):658-61. PubMed ID: 17274369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visualizing dendritic cell networks in vivo.
    Lindquist RL; Shakhar G; Dudziak D; Wardemann H; Eisenreich T; Dustin ML; Nussenzweig MC
    Nat Immunol; 2004 Dec; 5(12):1243-50. PubMed ID: 15543150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.
    Schuler P; Contassot E; Irla M; Hugues S; Preynat-Seauve O; Beermann F; Donda A; French LE; Huard B
    Cancer Res; 2008 Oct; 68(20):8410-8. PubMed ID: 18922914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses.
    Bedoui S; Prato S; Mintern J; Gebhardt T; Zhan Y; Lew AM; Heath WR; Villadangos JA; Segura E
    J Immunol; 2009 Apr; 182(7):4200-7. PubMed ID: 19299718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory.
    Scholer A; Hugues S; Boissonnas A; Fetler L; Amigorena S
    Immunity; 2008 Feb; 28(2):258-70. PubMed ID: 18275834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CCL21-induced immune cell infiltration.
    Ashour AE; Turnquist HR; Singh RK; Talmadge JE; Solheim JC
    Int Immunopharmacol; 2007 Feb; 7(2):272-6. PubMed ID: 17178395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
    Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.